Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.
Login5 requirements across 5 categories
Sign up to view complete requirements and analysis
9 documents available with AI summaries
This document contains the tender conditions for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kauno klinikos.
This document contains the special terms and conditions for the purchase and sale of the medication Polatuzumab vedotin.
This document is the European Single Procurement Document (ESPD) Annex 3, used for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kaunas Clinics.
This document contains a tender notice for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.
This document contains the general terms and conditions for the purchase and sale of goods, specifically defining terms and outlining the interpretation and hierarchy of contract documents in the context of procuring the medication Polatuzumab vedotin.
This document contains the technical specification for the drug Polatuzumab vedotin, outlining requirements for its registration, labeling, and shelf life.
This document contains a price list for the medication Polatuzumab vedotin, specifying its quantity, unit price, and other relevant details for a tender.
This document contains the structure for a complete tender submission, requiring a file upload for the 'File' criterion.
This document contains a request for information regarding participation in a criminal organization as an exclusion criterion for the tender of Polatuzumab vedotin.
Sign up to view document summaries and analysis
This tender for Polatuzumab vedotin is generally well-structured with clear documentation, but lacks specific details on evaluation criteria and financial aspects, impacting its overall completeness and practicality.
The tender adheres to EU procurement directives and utilizes standard procedures. The CPV code is appropriate. However, the absence of a revealed date for opening and the lack of specified evaluation criteria are minor procedural shortcomings.
The tender title, description, and classification are clear. Key documents like the ESPD, tender conditions, and technical specifications are provided, offering a good understanding of the procurement's nature. However, the lack of explicit eligibility and technical capability requirements leaves some ambiguity.
Most basic information is present, including the organization, reference, and contract duration. Several essential documents are attached. However, the estimated value is not disclosed, and specific requirements for exclusion, eligibility, technical, and financial capabilities are missing, reducing overall completeness.
The tender is open and utilizes e-procurement, promoting fairness. The CPV code is standard. The value is not disclosed, which is a minor concern for transparency. There are no apparent requirements tailored to specific companies.
The tender is EU funded and uses e-procurement, which are positive. However, the lack of explicit information on e-submission process details, contract start date, and financing details beyond 'EU Funded' limits its practicality.
Key fields such as title, reference, organization, and CPV code are populated correctly. The dates provided are logical, and there are no reported disputes or suspensions. The contract duration is clearly stated.
The tender is marked as EU funded, which often implies adherence to certain standards. However, there are no explicit mentions of green procurement, social aspects, or innovation within the provided information.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required